BIOMAT Database Logo BIOMAT Database Logo

Letter: Radioimmunoassay of fibrinogen-degradation products. 1974

T S Edgington, and E F Plow

UI MeSH Term Description Entries
D007106 Immune Sera Serum that contains antibodies. It is obtained from an animal that has been immunized either by ANTIGEN injection or infection with microorganisms containing the antigen. Antisera,Immune Serums,Sera, Immune,Serums, Immune
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D005340 Fibrinogen Plasma glycoprotein clotted by thrombin, composed of a dimer of three non-identical pairs of polypeptide chains (alpha, beta, gamma) held together by disulfide bonds. Fibrinogen clotting is a sol-gel change involving complex molecular arrangements: whereas fibrinogen is cleaved by thrombin to form polypeptides A and B, the proteolytic action of other enzymes yields different fibrinogen degradation products. Coagulation Factor I,Factor I,Blood Coagulation Factor I,gamma-Fibrinogen,Factor I, Coagulation,gamma Fibrinogen
D005342 Fibrinolysis The natural enzymatic dissolution of FIBRIN. Fibrinolyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

T S Edgington, and E F Plow
Determination of urinary fibrin/fibrinogen degradation products by radioimmunoassay.
September 1976, Scandinavian journal of clinical and laboratory investigation,
T S Edgington, and E F Plow
Specific and sensitive determination of fibrinogen-degradation products by radioimmunoassay.
November 1973, Lancet (London, England),
T S Edgington, and E F Plow
Characterisation of serum fibrinogen degradation products using gel chromatography and radioimmunoassay.
June 1977, Thrombosis and haemostasis,
T S Edgington, and E F Plow
[Letter: Determination of fibrinogen degradation products in joint effusions].
April 1974, La Nouvelle presse medicale,
T S Edgington, and E F Plow
Fibrinogen degradation products.
June 1971, The New England journal of medicine,
T S Edgington, and E F Plow
[Fibrinogen degradation products].
January 1998, Nihon rinsho. Japanese journal of clinical medicine,
T S Edgington, and E F Plow
Immunological characterization of early fibrinogen degradation products. Radioimmunoassay of fragments released from the Aalpha-chain of fibrinogen.
May 1976, Thrombosis research,
T S Edgington, and E F Plow
Reaction of plasmic degradation products of fibrinogen in the radioimmunoassay of human fibrinopeptide A.
June 1975, Blood,
T S Edgington, and E F Plow
Fibrinogen-fibrin degradation products.
January 1980, Annals of clinical and laboratory science,
T S Edgington, and E F Plow
Radioimmunoassay of fibrinogen and its proteolysis products.
November 1968, Thrombosis et diathesis haemorrhagica,
Copied contents to your clipboard!